There are thousands of healthcare apps for consumer smartphone and tablet users, but a recent study found that fewer than half of available patient-facing health apps appear likely to help users.
Mobile health (mHealth) devices and smartphone apps have drawn regulatory attention and concern among health information management (HIM) and privacy and security professionals. But what does the future of mHealth hold for HIM professionals, patients, and clinicians?
Cassi Birnbaum, MS, RHIA, FAHIMA, CPHQ, vice president of HIM for Peak Health Solutions in San Diego, CA, and incoming AHIMA president/chair-elect spoke with the Journal of AHIMA about some of the consumer engagement issues her session, “The Role of the HIM Professional in Engaging Consumers in Healthcare Decision Making,” will explore.
The US Food and Drug Administration (FDA) will only exert its considerable oversight powers over mobile health applications and technologies that are likely to pose an adverse effect if used incorrectly, according to final guidance released by the agency on Monday, Sept. 23.